QI
PRTA icon

QS Investors’s Prothena Corp PRTA Stock Holding History

QS Investors’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-600
Closed -$7K – 1456
2020
Q2 		$7K Hold
600
– – ﹤0.01% 1586
2020
Q1 		$7K Buy
+600
New +$7.27K ﹤0.01% 1564
2019
Q3 		– Sell
-500
Closed -$6K – 1655
2019
Q2 		$6K Hold
500
– – ﹤0.01% 1586
2019
Q1 		$7K Buy
+500
New +$6.24K ﹤0.01% 1580
2018
Q1 		– Sell
-900
Closed -$34K – 1983
2017
Q4 		$34K Hold
900
– – ﹤0.01% 1518
2017
Q3 		$58K Hold
900
– – ﹤0.01% 1489
2017
Q2 		$49K Hold
900
– – ﹤0.01% 1531
2017
Q1 		$50K Buy
+900
New +$47.3K ﹤0.01% 1519
2016
Q1 		– Sell
-4
Closed -$1K – 2046
2015
Q4 		$1K Buy
+4
New +$241 ﹤0.01% 1766

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QS Investors's PRTA Position: Q3 2020 in Review

QS Investors sold out of Prothena Corp (PRTA) in Q3 2020, closing a stake of 600 shares — an estimated $7K sold.

QS Investors first reported a position in PRTA in Q4 2015 and held it in 9 quarters. The position peaked at $58K in Q3 2017. 140 funds tracked by Wall St. Rank hold PRTA as of Q3 2020.

  • QS Investors reported no remaining Prothena Corp position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 600 Prothena Corp shares in Q3 2020, an estimated $7K.
  • QS Investors first reported a position in Prothena Corp in Q4 2015 and held it in 9 quarters.
  • QS Investors's Prothena Corp position peaked at $58K in Q3 2017.
  • 140 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.